FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SITAGLIPTIN
异名/同义词(2R)-4-OXO-4-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE
1,2,4-TRIAZOLO(4,3-A)PYRAZINE-7(8H)-PROPANAMINE, 5,6-DIHYDRO-.GAMMA.-OXO-3-(TRIFLUOROMETHYL)-.ALPHA.-((2,4,5-TRIFLUOROPHENYL)METHYL)-, (.ALPHA.R)-
LEZ763
LEZ-763
SITAGLIPTIN
SITAGLIPTIN [EMA EPAR]
SITAGLIPTIN [HSDB]
SITAGLIPTIN [INN]
SITAGLIPTIN [MI]
SITAGLIPTIN [USAN]
SITAGLIPTIN [VANDF]
SITAGLIPTIN [WHO-DD]
ZITUVIMET COMPONENT SITAGLIPTIN
ZITUVIO
CAS登记号486460-32-6
物质唯一标识(Unique Ingredient Identifier)QFP0P1DV7Z
分子式C16H15F6N5O
国际化合物标识(International Chemical Identifier,InChI)MFFMDFFZMYYVKS-SECBINFHSA-N
SMILESc1(n2c(nn1)CN(C(=O)C[C@H](N)Cc3c(cc(c(c3)F)F)F)CC2)C(F)(F)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System